New Study documents COVID19 Vaccine harms - Low platelets, GBS, Myocarditis - I unpack
Vinay Prasad MD MPH・20 minutes read
The paper discusses safety concerns related to the COVID-19 vaccine, highlighting adverse events such as myocarditis and Bell's palsy, especially in young individuals and those who have recovered from COVID-19. AstraZeneca has halted their COVID-19 vaccine production due to safety concerns like vaccine-induced thrombocytopenia and thrombosis, raising questions about the risk-benefit analysis and the potential impact of adverse events on different populations.
Insights
- The paper in the journal Vaccine discusses various safety concerns related to COVID-19 vaccines, including myocarditis, Bell's palsy, and seizures, potentially overlooked in young individuals and those who have recovered from COVID-19.
- AstraZeneca's halt in COVID-19 vaccine production due to concerns like thrombocytopenia and thrombosis underscores the importance of addressing safety signals and conducting thorough risk-benefit analyses, especially in different age groups, to ensure transparency and accurate representation of vaccine impacts.
Get key ideas from YouTube videos. It’s free
Recent questions
What are the safety concerns related to the COVID-19 vaccine?
Various safety concerns include myocarditis, Bell's palsy, seizures, and more.
Why did AstraZeneca halt COVID-19 vaccine production?
Due to safety concerns like vaccine-induced thrombocytopenia and thrombosis.
How do adverse events post-vaccination vary among different populations?
Young men between 16 and 24 are at higher risk for myocarditis.
What criticisms have been raised regarding public health strategies for vaccination?
Criticisms include potential harm, lack of benefit proof, and the need for better research and transparency.
What are the key safety signals for vaccine-related issues post-vaccination?
Notable safety signals include ITP, thrombocytopenia, febrile seizures, and more.
Related videos
Summary
00:00
"COVID-19 Vaccine Safety Signals Overlooked"
- A new paper in the journal Vaccine discusses the adverse events related to the COVID-19 vaccine, based on an observational analysis of 99 million individuals.
- The paper highlights safety concerns such as myocarditis, pericarditis, ITP, Guillain-Barre syndrome, Bell's palsy, pulmonary embolism, seizures, and more.
- The study suggests that safety signals related to the vaccine have been overlooked, particularly in young individuals and those who have recovered from COVID-19.
- AstraZeneca has announced the cessation of their COVID-19 vaccine production due to safety concerns, specifically vaccine-induced thrombocytopenia and thrombosis.
- The paper reveals concerning safety signals for various adverse events post-vaccination, including myocarditis, Bell's palsy, acute disseminated encephalomyelitis, seizures, and more.
- The study indicates an underestimation of adverse events due to potential missed cases and incomplete electronic health records.
- The paper fails to address that adverse events affect different populations unequally, with young men between 16 and 24 being at higher risk for myocarditis post-vaccination.
- The study does not adequately break down the risk-benefit analysis by age group, potentially leading to a misrepresentation of the vaccine's impact.
- Claims that COVID-19 is always worse than vaccine adverse events are criticized for not considering the true denominator of COVID-19 cases and the vaccine's inability to prevent infection.
- The paper's methodology is questioned for not conducting a seroprevalence study to accurately assess the impact of COVID-19 and vaccination on the population.
12:34
Vaccine Safety Concerns and Lack of Evidence
- Vaccines and infections are discussed, highlighting concerns of dishonesty in literature.
- Lack of evidence of efficacy in young populations, with flawed case control and observational studies.
- Safety signals for vaccine-related issues like ITP, thrombocytopenia, febrile seizures, and more are noted.
- Different age groups may experience varying outcomes from vaccines, with potential harm for young individuals.
- Public health strategies, including aggressive vaccination campaigns, are criticized for potential harm and lack of benefit proof, emphasizing the need for better research and transparency.
